Detalhe da pesquisa
1.
The therapeutically actionable long non-coding RNA 'T-RECS' is essential to cancer cells' survival in NRAS/MAPK-driven melanoma.
Mol Cancer
; 23(1): 40, 2024 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38383439
2.
BRAFi/MEKi in patients with metastatic melanoma: predictive factors of complete response.
Future Oncol
; 15(2): 133-139, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30196713
3.
Update on advanced melanoma treatments: small molecule targeted therapy, immunotherapy, and future combination therapies.
Wien Med Wochenschr
; 169(13-14): 314-322, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28091975
4.
Etanercept, adalimumab, and ustekinumab in psoriasis: analysis of 209 treatment series in Austria.
J Dtsch Dermatol Ges
; 15(3): 309-317, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28240404
5.
Etanercept, Adalimumab und Ustekinumab bei Psoriasis: Analyse von 209 Behandlungsreihen in Österreich.
J Dtsch Dermatol Ges
; 15(3): 309-318, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28252852
6.
The infliximab biosimilar in the treatment of moderate to severe plaque psoriasis.
J Am Acad Dermatol
; 75(4): 736-739, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27473452
7.
Risk factors related to late metastases in 1,372 melanoma patients disease free more than 10 years.
Int J Cancer
; 136(10): 2453-7, 2015 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25331444
8.
Detection of GNAQ mutations and reduction of cell viability in uveal melanoma cells with functionalized gold nanoparticles.
Biomed Microdevices
; 17(1): 15, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25653058
9.
Comparative profile of cutaneous adverse events: BRAF/MEK inhibitor combination therapy versus BRAF monotherapy in melanoma.
J Am Acad Dermatol
; 71(6): 1102-1109.e1, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25440439
10.
Mycoplasma-pneumoniae-assoziierte Mukositis mit Hautbeteiligung - ein Fallbericht.
J Dtsch Dermatol Ges
; 17(2): 184-185, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30762956
11.
Mycoplasma pneumoniae-associated mucositis with cutaneous involvement - a case report.
J Dtsch Dermatol Ges
; 17(2): 184-185, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30507029
12.
The therapeutically actionable long non-coding RNA 'T-RECS' is essential to cancer cells' survival in NRAS/MAPK-driven melanoma.
Res Sq
; 2023 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38077055
13.
Novel Lymphocyte-Independent Antitumor Activity by PD-1 Blocking Antibody against PD-1+ Chemoresistant Lung Cancer Cells.
Clin Cancer Res
; 29(3): 621-634, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36165915
14.
Melanoma risk during immunomodulating treatment.
Melanoma Res
; 32(6): 411-418, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35993892
15.
Immune Check Point Inhibitors in Primary Cutaneous T-Cell Lymphomas: Biologic Rationale, Clinical Results and Future Perspectives.
Front Oncol
; 11: 733770, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34485162
16.
Phenotypical Markers, Molecular Mutations, and Immune Microenvironment as Targets for New Treatments in Patients with Mycosis Fungoides and/or Sézary Syndrome.
J Invest Dermatol
; 141(3): 484-495, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33162051
17.
Genetic mutations in primary malignant melanoma of the esophagus: case report and literature review.
G Ital Dermatol Venereol
; 155(5): 680-682, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33295742
18.
A meta-analysis of melanoma risk in industrial workers.
Melanoma Res
; 30(3): 286-296, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30371537
19.
The large spectrum of Spitzoid tumors: a retrospective survival study.
G Ital Dermatol Venereol
; 154(3): 315-320, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28704985
20.
MEK/CDK4,6 co-targeting is effective in a subset of NRAS, BRAF and 'wild type' melanomas.
Oncotarget
; 9(79): 34990-34995, 2018 Oct 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30405888